TMO - Spark Newswire

1 minute read

Thermo Fisher’s Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers

Today, 8:11 AM

The FDA approved Thermo Fisher Scientific Inc’s (NYSE:TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to select patients with RET-fusion…

LLY

1 minute read

FDA
News

Thermo Fisher Scientific Announces FDA Approval Of Oncomine Dx Target Test As First NGS-Based Companion Diagnostic To Aid In Therapy Selection For Patients With RET Mutations/Fusions In Thyroid Cancer

By Michael Horton

Yesterday, 4:33 PM

-Reuters

TMO

1 minute read

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

By Vandana Singh

Yesterday, 2:14 PM

The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…

1 minute read

News

Thermo Fisher Scientific Invests $160M to Expand Bioproduction Capacity in Greater Boston

By Charles Gross

September 20, 6:07 AM

hermo Fisher Scientific Inc., today opened a new biomanufacturing facility in Chelmsford, Massachusetts. The $160 million, 85,000-square-foot facility will help meet growing demand for the biologic materials needed to produce vaccines and breakthrough therapies for cancer and other diseases.

TMO

1 minute read

HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here

By Lisa Levin

September 12, 8:44 AM

Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in pre-market trading.

BIDU

1 minute read

Barclays Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $595

By Benzinga Newsdesk

September 12, 7:13 AM

Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $685 to $595.

TMO

3 minute read

Trump Ally Dr. Oz Hyped Unapproved ‘Covid Cures’ From Companies He Owns Shares Of

By Chris Katje

September 8, 11:42 AM

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

MCK

2 minute read

Check Out What Whales Are Doing With TMO

By Benzinga Insights

September 1, 2:18 PM

Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

TMO

1 minute read

No More Free COVID-19 At-Home Tests, Federal Government Says

By Vandana Singh

August 29, 8:20 AM

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

1 minute read

Analyst Ratings

Expert Ratings for Thermo Fisher Scientific

By Benzinga Insights

August 25, 11:10 AM

Over the past 3 months, 5 analysts have published their opinion on Thermo Fisher Scientific (NYSE:TMO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

TMO

Feed Symbols: TMO